DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Samsung in talks with Japan’s Nipro for medical device division sale May sharpen focus on diagnostic imaging solutions

Philips inks 15-year $75 million MES deal with Children’s Health in Texas Are these contracts the future of value-based care?

Medtronic in $1.6 billion deal for Mazor Robotics 'We believe robotic-assisted procedures are the future of spine surgery'

DOJ clears Cigna, Express Scripts deal The $52 billion mega-deal will move forward

Trimedx to acquire Aramark's health tech business for $300 million Expands reach to more than 500 healthcare providers

UPDATE: Agfa responds to acquisition interest from Kanteron Systems X-ray leader 'has decided not to engage in discussions' at this time

Dr. Charles Stacey Accreditation Council for Medical Affairs appoints Accera CEO to board of governors

Johnson & Johnson acquires Emerging Implant Technologies GmbH Company aims to improve spinal fusion technology and outcomes

Will Agfa-Gevaert be acquired by Kanteron Systems? Software company pitches buy, points to stagnant Agfa Healthcare revenue and synergies

Stryker to acquire Invuity for $7.40 per share in cash Develops tools to boost visualization during surgery

Researchers say device tax hurt investment in research and development

por Thomas Dworetzky , Contributing Reporter
A new Iowa State University study looking at data from 2006 and 2015 shows that firms have cut R&D thanks to the the Affordable Care Act's medical device tax.

"Highly advanced equipment in hospitals is a critical aspect of medical care," said Daeyong Lee, an assistant professor of human development and family studies at ISU. "Some devices, such as coronary stents, require high research investment. If medical device firms stop or reduce that investment, we won't have better equipment and devices for complicated surgeries or procedures."

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



His study, which is appearing in the journal Research Policy, looked at the 2.3 percent excise tax imposed on medical devices in 2013.

“The medical device tax significantly reduced the R&D investment, sales revenues, gross margins, earnings, and return on equity for medical device manufacturing firms,” said Lee.

The cuts he found included:

-R&D expenditures - $34 million
-Sales revenue - $188 million
-Gross margins - $375 million
-Earnings - $68 million

His research looked first at the real cost to makers, but discovered that the tax also hit operating and marketing costs.

The tax is surprisingly broad, too. It doesn't just hit the high end, but is slapped on everything from needles and syringes to coronary stents, defibrillators and irradiation equipment -- although it does exempt hearing aids, eyeglasses and contact lenses.

Lee also looked at different ways to mitigate the tax impact for firms, including raising prices, which did not really happen, he said, because of the buying clout of the bigger consumers like large hospitals and clinics.

Instead of bumping up pricing, medical device makers have responded by spreading out their customer base and boosting international sales – which don't get hit with the tax.

“The device tax significantly increased their international sales revenue, international diversification, and customer diversification in the U.S. markets,” stated Lee.

Firms also slashed sales operating costs and general and administrative overhead, but continued to spend for advertising and labor.

The congressional appropriations act in 2015 had a two-year moratorium on the medical device excise tax. Then, in January, that was lengthened until 2020, at which time, industry leaders praised the decision.

“AdvaMed applauds passage of the two-year suspension of the medical device tax,” president and CEO Scott Whitaker of the Advanced Medical Technology Association said in a statement at the time. “This suspension is good news for American patients and American innovation. Congress' action – just days before medical technology innovators were set to start cutting checks to the IRS – means funds will not be diverted from current investments in jobs, capital improvements and research into new treatments and cures.”
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS